IP Library Patent Application 11196950
Patent Application
App. No. 11/196,950

Method and compositions for preparing a compound using a benzoylating agent essentially free of ring chlorination

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/196,950
Abstract

This invention relates to methods and compositions for preparing compounds using a benzoylating agent essentially free of ring chlorination. In one alternative embodiment, the present invention relates to methods and compositions for preparing taxanes essentially free of ring chlorinated impurities. In another alternative embodiment, the present invention comprises methods of converting taxane amine with a benzoylating agent essentially free of ring chlorination.

Claims (33)

1 . A method for producing a taxane comprising contacting a taxane amine with a benzoylating agent essentially free from ring chlorination to form a taxane compound.

2 . The method of claim 1 , wherein the benzoylating agent is benzoyl chloride.

3 . The method of claim 1 , wherein the benzoylating agent is benzoic anhydride.

4 . The method of claim 1 , wherein the benzoylating agent is benzoic acid with one or more coupling agents.

5 . The method of claim 4 , wherein the coupling agent is DCC or EDAC.

6 . The method of claim 1 , wherein the taxane is paclitaxel, its precursors or analogs thereof.

7 . A compound comprising a taxane having a benzoyl group essentially free from ring chlorination made by the process of contacting a taxane amine with a benzoylating agent essentially free from ring chlorination.

8 . The compound of claim 7 , wherein the benzoylating agent is benzoyl chloride.

9 . The compound of claim 7 , wherein the benzoylating agent is benzoic anhydride.

10 . The compound of claim 7 , wherein the benzoylating agent is benzoic acid with one or more coupling agents.

11 . The compound of claim 7 , wherein the coupling agents are selected from the group consisting of DCC and EDAC.

12 . The compound of claim 7 , wherein the taxane is paclitaxel, its precursors or analogs thereof.

13 . A method for producing a pharmaceutical compound comprising contacting a compound requiring one or more benzoyl functional groups with a benzoylating agent essentially free from ring chlorination.

14 . The method of claim 13 , wherein the benzoylating agent is benzoyl chloride.

15 . The method of claim 13 , wherein the benzoylating agent is benzoic anhydride.

16 . The method of claim 13 , wherein the benzoylating agent is benzoic acid with one or more coupling agents.

17 . The method of claim 16 , wherein the coupling agent is DCC or EDAC.

18 . A reaction product comprising a pharmaceutical compound having a benzoyl group essentially free from ring chlorination made by the process of contacting a compound requiring one or more benzoyl functional groups with a benzoylating agent essentially free from ring chlorination.

19 . The method of claim 18 , wherein the benzoylating agent is benzoyl chloride.

20 . The method of claim 18 , wherein the benzoylating agent is benzoic anhydride.

21 . The method of claim 18 , wherein the benzoylating agent is benzoic acid with one or more coupling agents.

22 . The method of claim 21 , wherein the coupling agent is DCC or EDAC.

23 . The benzoylating agent of claim 1 , wherein the amount of ring-chlorinated molecules in the benzoylating agent is less than about 10 ppm.

24 . The benzoylating agent of claim 7 , wherein the amount of ring-chlorinated molecules in the benzoylating agent is less than about 10 ppm.

25 . The benzoylating agent of claim 1 , herein the amount of ring-chlorinated molecules in the benzoylating agent is less than 50 ppm.

26 . The benzoylating agent of claim 1 , wherein the amount of ring-chlorinated molecules in the benzoylating agent is less than 100 ppm.

27 . The benzoylating agent of claim 1 , wherein the amount of ring-chlorinated molecules in the benzoylating agent is less than 200 ppm.

28 . The benzoylating agent of claim 1 , wherein the amount of ring-chlorinated molecules in the benzoylating agent is less than 500 ppm.

29 . The benzoylating agent of claim 7 , wherein the amount of ring-chlorinated molecules in the benzoylating agent is less than 500 ppm.

30 . A method of producing an amide compound comprising contacting an amine compound requiring one or more benzoyl functional groups with a benzoylating agent essentially free from ring chlorination.

31 . The method of claim 29 , wherein the amide compound is a benzomide compound.

32 . An amide compound comprising contacting an amine compound requiring one or more benzoyl functional groups with a benzoylating agent essentially free from ring chlorination.

33 . The amide compound of claim 31 , wherein the amide compound is a benzomide compound.

Assignments (5)
CHANGE OF NAME Recorded Jan 14, 2010
From: PHYTON, INC.
To: PHYTON HOLDINGS, LLC
Reel/Frame 023786/0389 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2010
From: NATURAL PHARMA CANADA, ULC; NATURAL PHARMACEUTICALS, INC.
To: PHYTON, INC.
Reel/Frame 023768/0757 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2010
From: NATURAL PHARMA CANADA, ULC; NATURAL PHARMACEUTICALS, INC.
To: PHYTON, INC.
Reel/Frame 023768/0626 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2010
From: NATURAL PHARMA CANADA, ULC; NATURAL PHARMACEUTICALS, INC.
To: PHYTON, INC.
Reel/Frame 023741/0771 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2005
From: JOHNSON, JAMES H.; HAND, BARRY J.; GALLAGHER, REX T.
To: NATURAL PHARMACEUTICALS, INC.
Reel/Frame 016942/0875 →